We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEO icon
2476
Telecom Argentina
TEO
$5.84B
$970K ﹤0.01%
189,802
-216,780
-53% -$1.11M
LIDRW icon
2477
CALL
AEye Inc Warrant
LIDRW
$254K
$969K ﹤0.01%
200,000
ECL icon
2478
Ecolab
ECL
$79.8B
$964K ﹤0.01%
+4,113
New +$930K
NDACW
2479
CALL
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$960K ﹤0.01%
98,311
CCO icon
2480
Clear Channel Outdoor Holdings
CCO
$1.22B
$959K ﹤0.01%
+289,604
New +$901K
BKU icon
2481
Bankunited
BKU
$3.33B
$951K ﹤0.01%
22,493
-45,581
-67% -$1.91M
BODY.WS
2482
CALL
DELISTED
The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
BODY.WS
$947K ﹤0.01%
400,000
+134,232
+51% +$108K
PHAS
2483
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$945K ﹤0.01%
362,170
+143,293
+65% +$433K
NEM icon
2484
PUT
Newmont
NEM
$96.2B
$943K ﹤0.01%
15,200
-10,100
-40% -$572K
MMSI icon
2485
Merit Medical Systems
MMSI
$4.82B
$942K ﹤0.01%
15,134
-13,217
-47% -$886K
LIAN
2486
DELISTED
LianBio American Depositary Shares
LIAN
$942K ﹤0.01%
+152,948
New +$1.75M
DORM icon
2487
Dorman Products
DORM
$4.22B
$940K ﹤0.01%
+8,313
New +$902K
NEXT icon
2488
NextDecade
NEXT
$1.68B
$940K ﹤0.01%
329,783
-213,182
-39% -$711K
AVAL icon
2489
Grupo Aval
AVAL
$5.82B
$939K ﹤0.01%
183,825
-195,635
-52% -$1.1M
NYT icon
2490
New York Times
NYT
$12.6B
$935K ﹤0.01%
19,349
-295,300
-94% -$14.6M
SITM icon
2491
SiTime
SITM
$13.8B
$935K ﹤0.01%
+3,197
New +$838K
CDAQW
2492
CALL
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$931K ﹤0.01%
+96,710
New +$76.7K
LYLT
2493
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$928K ﹤0.01%
+30,894
New +$997K
TDS icon
2494
Telephone and Data Systems
TDS
$3.87B
$926K ﹤0.01%
+46,001
New +$897K
IUSG icon
2495
iShares Core S&P US Growth ETF
IUSG
$30.4B
$923K ﹤0.01%
+7,979
New +$889K
TXT icon
2496
Textron
TXT
$14.9B
$922K ﹤0.01%
+11,941
New +$887K
BZUN
2497
Baozun
BZUN
$179M
$918K ﹤0.01%
+66,078
New +$1.08M
ENV
2498
DELISTED
ENVESTNET, INC.
ENV
$918K ﹤0.01%
+11,581
New +$943K
CMRX
2499
DELISTED
Chimerix, Inc.
CMRX
$916K ﹤0.01%
142,562
-288,307
-67% -$1.73M
AXP icon
2500
PUT
American Express
AXP
$224B
$915K ﹤0.01%
5,600
+3,800
+211% +$648K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.